Medicared For All Logo

Waqas Rehman in Flemington, New Jersey

Home New Jersey Flemington

Waqas Rehman has Hematology/oncology as his primary medical specialty. Their primary office is: 2100 Wescott Dr in Flemington, New Jersey.

They're a part of the: Hunterdon Hematology Oncology, Llc medical group which has around 6 members. You can call their office at 908-237-1201 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Northeastern Ohio University College Of Medicine and graduated in 2007 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Waqas Rehman Office Phone and Directions

Waqas Rehman
Hunterdon Hematology Oncology, Llc
2100 Wescott Dr
Flemington, New Jersey 08822
908-237-1201


Patient Ratings
Please rate your experience with Waqas Rehman below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 908-237-1201


Enter a starting address:


Healthcare Info for Waqas Rehman

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Northeastern Ohio University College Of Medicine
Graduation Year: 2007
The Primary Medical Specialty for Waqas Rehman is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 3476797721
NPI #: 1750546610
NPI Created On: 07/21/2008
NPI Last Updated Listed as: 12/05/2013
Primary Taxonomy Code: 207RH0003X
License Number:
MA09348400
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • AmeriHealth HMO, Inc.
  • Humana
  • Oscar Garden State Insurance Corporation
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Blood test, basic group of blood chemicals
  3. Blood test, comprehensive group of blood chemicals
  4. Manual urinalysis test with examination using microscope
  5. Vitamin d-3 level
  6. Calcium level
  7. Blood creatinine level
  8. Lactate dehydrogenase (enzyme) level
  9. Magnesium level
  10. Phosphate level
  11. Urea nitrogen level to assess kidney function
  12. Complete blood cell count (red cells, white blood cell, platelets), automated test
  13. Vaccine for influenza for injection into muscle
  14. Hydration infusion into a vein 31 minutes to 1 hour
  15. Hydration infusion into a vein
  16. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  17. Infusion into a vein for therapy, prevention, or diagnosis
  18. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  19. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  20. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642803

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642805

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642807

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642809

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642813

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642811

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $1

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642817

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642819

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788642821

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Hematology/oncology Professionals in Flemington

2100 Wescott Dr
Flemington, NJ
Hunterdon Hematology Oncology, Llc

2100 Wescott Dr
Flemington, NJ
Hunterdon Hematology Oncology, Llc

2100 Wescott Dr
Flemington, NJ
Hunterdon Hematology Oncology, Llc

Providers in Hunterdon Hematology Oncology, Llc

1.Myron Bednar Md

2100 Wescott Dr
Flemington Nj 08822-4603
Hunterdon Hematology Oncology, Llc
Hematology

2.Kenneth Blankstein

2100 Wescott Dr
Flemington Nj 08822-4603
Hunterdon Hematology Oncology, Llc
Hematology/oncology

3.Andrew Greenberg Md

2100 Wescott Dr
Flemington Nj 08822-4603
Hunterdon Hematology Oncology, Llc
Radiation Oncology

4.Swee Jian Ngeow

2100 Wescott Dr
Flemington Nj 08822-4603
Hunterdon Hematology Oncology, Llc
Hematology/oncology

5.Waqas Rehman

2100 Wescott Dr
Flemington Nj 08822-4603
Hunterdon Hematology Oncology, Llc
Hematology/oncology

6.Megha Shah

2100 Wescott Dr
Flemington Nj 08822-4603
Hunterdon Hematology Oncology, Llc
Hematology/oncology

View all 6 members of Hunterdon Hematology Oncology, Llc medical group